Literature DB >> 32060676

Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach.

Edgar López-López1, Obdulia Rabal2, Julen Oyarzabal2, José L Medina-Franco3.   

Abstract

In this work, we analyze the structure-activity relationships (SAR) of epigenetic inhibitors (lysine mimetics) against lysine methyltransferase (G9a or EHMT2) using a combined activity landscape, molecular docking and molecular dynamics approach. The study was based on a set of 251 G9a inhibitors with reported experimental activity. The activity landscape analysis rapidly led to the identification of activity cliffs, scaffolds hops and other active an inactive molecules with distinct SAR. Structure-based analysis of activity cliffs, scaffold hops and other selected active and inactive G9a inhibitors by means of docking followed by molecular dynamics simulations led to the identification of interactions with key residues involved in activity against G9a, for instance with ASP 1083, LEU 1086, ASP 1088, TYR 1154 and PHE 1158. The outcome of this work is expected to further advance the development of G9a inhibitors.

Entities:  

Keywords:  Activity cliffs; Drug discovery; EHMT2; Epi-pharmacology; Scaffold hops; Structure–activity relationships

Year:  2020        PMID: 32060676     DOI: 10.1007/s10822-020-00298-x

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  6 in total

Review 1.  Recent progress on cheminformatics approaches to epigenetic drug discovery.

Authors:  Zoe Sessions; Norberto Sánchez-Cruz; Fernando D Prieto-Martínez; Vinicius M Alves; Hudson P Santos; Eugene Muratov; Alexander Tropsha; José L Medina-Franco
Journal:  Drug Discov Today       Date:  2020-09-30       Impact factor: 7.851

2.  7-Aminoalkoxy-Quinazolines from Epigenetic Focused Libraries Are Potent and Selective Inhibitors of DNA Methyltransferase 1.

Authors:  José L Medina-Franco; Edgar López-López; Liliam P Martínez-Fernández
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

3.  Expanding the Structural Diversity of DNA Methyltransferase Inhibitors.

Authors:  K Eurídice Juárez-Mercado; Fernando D Prieto-Martínez; Norberto Sánchez-Cruz; Andrea Peña-Castillo; Diego Prada-Gracia; José L Medina-Franco
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-27

4.  Tubulin Inhibitors: A Chemoinformatic Analysis Using Cell-Based Data.

Authors:  Edgar López-López; Carlos M Cerda-García-Rojas; José L Medina-Franco
Journal:  Molecules       Date:  2021-04-24       Impact factor: 4.411

Review 5.  EHMT2/G9a as an Epigenetic Target in Pediatric and Adult Brain Tumors.

Authors:  Barbara Kunzler Souza; Natalia Hogetop Freire; Mariane Jaeger; Caroline Brunetto de Farias; Algemir L Brunetto; André T Brunetto; Rafael Roesler
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

6.  Exploring the dynamic mechanism of allosteric drug SHP099 inhibiting SHP2E69K.

Authors:  Xin-Hua Lu; Wei-Ya Li; Shan Du; Li-Peng Li; Yang-Chun Ma; Liang Zhou; Jing-Wei Wu; Ying Ma; Run-Ling Wang
Journal:  Mol Divers       Date:  2021-01-03       Impact factor: 2.943

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.